Gastrointestinal Outcomes and Confounders in Cystic Fibrosis
Drucy Borowitz(University at Buffalo, State University of New York), James E. Heubi(Cincinnati Children's Hospital Medical Center), Susan S. Baker(GTx (United States)), Henkjan J. Verkade(University Medical Center Groningen), Virginia A. Stallings(Children's Hospital of Philadelphia), Robert C. De Lisle(Cystic Fibrosis Foundation), Mark E. Lowe(Washington University in St. Louis), Chris Taylor(St George's, University of London), Morteza Janghorbani(Cystic Fibrosis Foundation), Robert D. Baker(Women & Children's Hospital of Buffalo), Steven Lichtman(Cystic Fibrosis Foundation), Peter Lewindon(The University of Queensland), Steven L. Werlin(Greenville College), Ross N. Butler(Wirral University Teaching Hospital NHS Foundation Trust), M. Sinaasappel(Cystic Fibrosis Foundation), Lane L. Clarke(Cystic Fibrosis Foundation), John R. Semler(Cystic Fibrosis Foundation), Peter R. Durie(University of Toronto)
Journal of Pediatric Gastroenterology and Nutrition
August 30, 2005
Cited by 155
Related Papers
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k
Medical Image Computing and Computer-Assisted Intervention
|Research Explorer (The University of Manchester)|2009|1.6k
Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- <i>CFTR</i> Mutation
|New England Journal of Medicine|2010|802
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study
|The Lancet|2017|647
Guidelines for Evaluation and Treatment of Gastroesophageal Reflux in Infants and Children
|Journal of Pediatric Gastroenterology and Nutrition|2001|628